MedPage Today on MSN
Low testosterone may raise risk of 'extreme' prostate cancer progression
Results challenge view that high testosterone fuels prostate cancer growth ...
Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
February 1, 2012 — A new study suggests that vigorous physical activity will offer protection against prostate cancer progression because of its effects on DNA repair and cell-cycle pathways. The ...
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...
But as it turned out, his transition from military service to civilian life came with prostate cancer. It was during his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results